Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey
- PMID: 16503997
- PMCID: PMC1402270
- DOI: 10.1186/1477-7517-3-8
Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey
Abstract
Background: We sought to assess injection practices, means of acquiring and disposing of syringes, and utilization and knowledge of harm reduction resources among injection drug users (IDUs) entering methadone maintenance treatment (MMT).
Methods: Interviews with 100 consecutive patients, including 35 IDUs, entering a MMT program in the Bronx, NY.
Results: Utilization of unsafe syringe sources was reported by 69% of IDUs in our sample. Most (80%) IDUs reused syringes, and syringe sharing was also common. Fewer than half knew that non-prescription pharmacy purchase of syringes was possible. The most common means of disposing of injecting equipment were the trash (63%) and syringe exchange programs (49%).
Conclusions: These findings indicate that drug users entering treatment under-utilize sanctioned venues to obtain sterile syringes or safely dispose of used injection equipment. Programs providing services to drug users should adopt a proactive stance to address the safety and health issues faced by injectors.
Figures
Similar articles
-
Improving access to sterile syringes and safe syringe disposal for injection drug users in methadone maintenance treatment.J Subst Abuse Treat. 2006 Jul;31(1):51-7. doi: 10.1016/j.jsat.2006.03.009. J Subst Abuse Treat. 2006. PMID: 16814010
-
Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States metropolitan areas.J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S30-6. doi: 10.1097/00042560-199802001-00007. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9663621
-
Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):183-92. doi: 10.1097/00126334-200106010-00014. J Acquir Immune Defic Syndr. 2001. PMID: 11404541
-
Strategies to improve access to sterile syringes for injection drug users.AIDS Read. 2002 Dec;12(12):527-35. AIDS Read. 2002. PMID: 12518719 Review.
-
Community-based programs for safe disposal of used needles and syringes.J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S111-9. doi: 10.1097/00042560-199802001-00019. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9663633 Review.
Cited by
-
Resilience among IDUs: planning strategies to help injection drug users to protect themselves and others from HIV/HCV infections.Subst Use Misuse. 2012 Aug;47(10):1125-33. doi: 10.3109/10826084.2012.682324. Epub 2012 May 10. Subst Use Misuse. 2012. PMID: 22574849 Free PMC article.
-
Who purchases nonprescription syringes? Characterizing customers of the Expanded Syringe Access Program (ESAP).J Urban Health. 2009 Nov;86(6):946-50. doi: 10.1007/s11524-009-9356-5. J Urban Health. 2009. PMID: 19434499 Free PMC article.
-
High dead-space syringes and the risk of HIV and HCV infection among injecting drug users.Drug Alcohol Depend. 2009 Mar 1;100(3):204-13. doi: 10.1016/j.drugalcdep.2008.08.017. Epub 2008 Nov 11. Drug Alcohol Depend. 2009. PMID: 19004579 Free PMC article.
-
Policy implementation of methadone maintenance treatment and HIV infection: evidence from Hubei province, China.Subst Abuse Treat Prev Policy. 2013 Nov 5;8:38. doi: 10.1186/1747-597X-8-38. Subst Abuse Treat Prev Policy. 2013. PMID: 24188659 Free PMC article.
-
Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now?J Urban Health. 2010 Jul;87(4):576-85. doi: 10.1007/s11524-010-9463-3. J Urban Health. 2010. PMID: 20535641 Free PMC article.
References
-
- U.S. Department of Health and Human Services, Public Health Service HIV prevention bulletin: Medical advice for persons who inject illicit drugs http://www.cdc.gov/idu/pubs/hiv_prev.htm May 9, 1997, Accessed March 9, 2004.
-
- Centers for Disease Control and Prevention Viral Hepatitis and Injection Drug Users. 2002. http://www.cdc.gov/idu/hepatitis/viral_hep_drug_use.htm Accessed May 31, 2004.
-
- Normand J, Vlahov D, Moses LE, (Eds) Preventing HIV transmission: The role of sterile needles and bleach. Washington, DC: National Academy Press; 1995. - PubMed
-
- Lurie P, Jones TS, Foley J. A sterile syringe for every drug user injection: How many injections take place annually, and how might pharmacists contribute to syringe distribution? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18:S45–S51. - PubMed
-
- Gleghorn AA, Wright-De Aguero L, Flynn C. Feasibility of one-time use of sterile syringes: A study of active injection drug users in seven United States metropolitan areas. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18:S30–S36. - PubMed
LinkOut - more resources
Full Text Sources